等待开盘 11-17 09:30:00 美东时间
0.000
0.00%
今日重点评级关注:韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从42美元升至44美元;HC Wainwright & Co.:维持WhiteFiber"买入"评级,目标价从34美元升至36美元
11-12 19:19
11月12日,Life360(LIF)收涨6.38%,报44.66美元,成交额3589.26万美元,市值36.51亿美元。 行情数据 • 开盘价:42.11美元...
11-12 06:13
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B of A Securities analyst Nitin Bansal downgraded Life360 Inc (NASDAQ:LIF) from Buy to Neutral an...
11-11 20:40
B of A Securities analyst Nitin Bansal downgrades Life360 (NASDAQ:LIF) from Buy to Neutral and lowers the price target from $60 to $45.
11-11 17:14
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
最新财报显示,Life360 2026财年第3季度实现: 营业收入:1.74亿美元 同比:增长39.87% 净利润:2249万美元 同比:增长129.65% 每...
11-11 00:00
11月10日,Life360(LIF)收跌4.96%,报45.02美元,成交额1.46亿美元,市值36.68亿美元。 行情数据 • 开盘价:47美元 • 最高价...
11-10 06:13
Life360 (NASDAQ:LIF) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.24 by 8.33 percent. This is a 136.36 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $174.137 million which be...
11-10 05:29
Life360 (NASDAQ:LIF) narrows FY2026 sales outlook from $650.000 million-$685.000 million to $665.000 million-$681.000 million vs $673.023 million estimate.
11-10 05:07
Genius Group Limited has announced that its Board of Directors has approved a dual listing on the Australian Securities Exchange (ASX) following the achievement of solvency and net working capital surplus milestones. The Company has achieved a positive net working capital surplus, with current assets exceeding current liabilities, enabling the formal application for a dual listing on ASX. Additionally, the Board has approved the expansion of the ...
11-04 13:00